Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 hours agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 7 days agovaccine for adults ages 60 and older. This will be the only RSV vaccine available in single-dose...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 7 days agoAfter a median follow-up time of 112 days — roughly...the shot proved 83.7% effective against lower...
Moderna wins second product approval with RSV vaccine
Market Watch· 7 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 4 days agoFDA approval comes after the successful Phase ...showed an 83.7% efficacy in preventing LRTD caused by RSV. The vaccine sustained protection over a...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Digital Journal· 7 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE ...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 4 days agoThe RSV vaccine will now be reviewed at the CDC's Advisory Committee on Immunization Practices...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 day agoModerna expects roll-out by the 2024/2025 RSV season mRESVIA is the only RSV product available in a...
Moderna's RSV Vaccine Approved by FDA
Medscape· 4 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.